BEHANDLUNG VON AUTOIMMUNERKRANKUNGEN
European patent · EP3145931 · In force
Register entry
- Publication number
- EP3145931
- Application number
- EP15795527
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- May 22, 2015
- Published
- Mar 29, 2017
- Granted
- Mar 31, 2021
- Protection ends at the latest
- May 21, 2035
- Next annual fee due
- May 31, 2027
- IPC classes
- C07D 487/04 (2006.01)C07D 403/00 (2006.01)A01N 43/54 (2006.01)A61K 31/496 (2006.01)A61K 31/506 (2006.01)A61K 31/04 (2006.01)A61P 37/06 (2006.01)
- Priority
- US 201462002724 P 23.05.2014
- PCT application
- PCT/US2015/032315 22.05.2015
- PCT publication
- WO2015/179847 26.11.2015
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jun 1, 2026
Change
Published in Swissreg on 01.06.2026
- Jun 1, 2025
Change
Published in Swissreg on 01.06.2025
- Jun 2, 2024
Change
Published in Swissreg on 02.06.2024
- Jun 9, 2023
Change
Published in Swissreg on 09.06.2023
- Feb 9, 2022
Change
Published in Swissreg on 09.02.2022
- Mar 31, 2021
Granted
Published in Swissreg on 31.03.2021
Parties
Inventor
ZHANG, Kai
San Diego, California 92196, US
NIESMAN, Michael
San Diego, CA 92196, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.